Disseminate and Recurrent Infundibular Folliculitis Treatment & Management

  • Author: Stephen W White, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Aug 15, 2011
 

Medical Care

  • Cooling, soothing emollients have been used for 30 years, with variable success, in disseminate and recurrent infundibular folliculitis (DRIF).
  • Corticosteroids have not been demonstrated effective, with the exception of a single case report by Hinds and Heald using potent topical corticosteroids.[3]
  • In 1999, Ruvikumar et al reported that psoralen plus ultraviolet light A (PUVA) therapy was successful in disseminate and recurrent infundibular folliculitis.[4]
  • In 1998 and again in 2004, Aroni et al reported successful treatment of disseminate and recurrent infundibular folliculitis with isotretinoin.[5]
Next

Consultations

Although unfamiliar to generalists, dermatologists should recognize disseminate and recurrent infundibular folliculitis.

Previous
Next

Activity

Limiting activity under hot, moist conditions may be necessary to prevent or relieve symptoms of disseminate and recurrent infundibular folliculitis.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Stephen W White, MD  Clinical Assistant Professor, Department of Dermatology, George Washington University Hospital; Chief, Sub-section of Dermatology, Suburban Hospital

Stephen W White, MD is a member of the following medical societies: American Academy of Dermatology, International Society of Dermatology, Society for Investigative Dermatology, and Society for Pediatric Dermatology

Disclosure: Nothing to disclose.

Coauthor(s)

Christopher R Gorman, MD  Bethesda Dermatology, Private Practice; Assistant Clinical Professor, George Washington University School of Medicine and Health Sciences; Staff Dermatologist, National Naval Medical Center

Christopher R Gorman, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

Specialty Editor Board

James Fulton Jr, MD, PhD  Center for Cosmetic Dermatology; Consultant, Vivant Pharmaceuticals, LLC

James Fulton Jr, MD, PhD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American Society for Laser Medicine and Surgery, Dermatology Foundation, International Society of Cosmetic and Laser Surgeons, and Skin Cancer Foundation

Disclosure: Vivant Pharmaceuticals Grant/research funds Consulting

Richard P Vinson, MD  Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Jeffrey Meffert, MD  Assistant Clinical Professor of Dermatology, University of Texas School of Medicine at San Antonio

Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous Chief Editor, William D. James, MD, to the development and writing of this article.

References
  1. Hitch JM, Lund HZ. Disseminate and recurrent infundibulo-folliculitis: report of a case. Arch Dermatol. Apr 1968;97(4):432-5. [Medline].

  2. Barriere H, Litoux P, Bureau B, Stalder JF. [Disseminate and recurrent infundibulo-folliculitis (Hitch and Lund)]. Ann Dermatol Venereol. Apr 1980;107(4):299-302. [Medline].

  3. Hinds GA, Heald PW. A case of disseminate and recurrent infundibulofolliculitis responsive to treatment with topical steroids. Dermatol Online J. Nov 15 2008;14(11):11. [Medline].

  4. Ravikumar BC, Balachandran C, Shenoi SD, Sabitha L, Ramnarayan K. Disseminate and recurrent infundibulofolliculitis: response to psoralen plus UVA therapy. Int J Dermatol. Jan 1999;38(1):75-6. [Medline].

  5. Aroni K, Grapsa A, Agapitos E. Disseminate and recurrent infundibulofolliculitis: response to isotretinoin. J Drugs Dermatol. Jul-Aug 2004;3(4):434-5. [Medline].

  6. Owen WR, Wood C. Disseminate and recurrent infundibulofolliculitis. Arch Dermatol. Feb 1979;115(2):174-5. [Medline].

  7. El Shabrawi-Caelen L, Soyer HP. Clinical Pathologic Challenge: Patchy pityriasiform lichenoid eczema. Am J Dermatopathol. Jun 2005;27(3):216, 258.

  8. White SW, Rodman OG. Disseminate and recurrent infundibulofolliculitis. J Assoc Military Dermatol. 1981;22-23.

Previous
Next
 
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.